ID   TTC-1318
AC   CVCL_AQ33
DR   Wikidata; Q54973232
RX   PubMed=19887553;
RX   PubMed=23665679;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 12,15
ST   D19S433: 14,15
ST   D21S11: 32.2
ST   D2S1338: 20,24
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 13,14
ST   FGA: 20,24.2
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 4
//
RX   PubMed=19887553; DOI=10.1158/1535-7163.MCT-09-0365; PMCID=PMC2783569;
RA   Hu K.-J., Lee C., Qiu D.-X., Fotovati A., Davies A., Abu-Ali S.,
RA   Wai D.H., Lawlor E.R., Triche T.J., Pallen C.J., Dunn S.E.;
RT   "Small interfering RNA library screen of human kinases and
RT   phosphatases identifies polo-like kinase 1 as a promising new target
RT   for the treatment of pediatric rhabdomyosarcomas.";
RL   Mol. Cancer Ther. 8:3024-3035(2009).
//
RX   PubMed=23665679; DOI=10.1038/onc.2013.129;
RA   Sokolowski E., Turina C.B., Kikuchi K., Langenau D.M., Keller C.;
RT   "Proof-of-concept rare cancers in drug development: the case for
RT   rhabdomyosarcoma.";
RL   Oncogene 33:1877-1889(2014).
//